Medtide, Inc. Class H

As of December 31, 2025, Medtide, Inc. Class H carries a market capitalization of 4.32B, placing it among publicly traded companies globally. Its enterprise value stands at 3.16B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Medtide, Inc. Class H's next confirmed earnings release is scheduled for March 3, 2027.

As of December 31, 2025, Medtide, Inc. Class H has 141.80M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Medtide, Inc. Class H maintains a current ratio of 6.40, meaning it holds 6.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Medtide, Inc. Class H's stock has declined approximately 36.76% over the past 52 weeks. The 50-day moving average sits at 21.07, while the 200-day moving average is 22.92.

As of December 31, 2025, Medtide, Inc. Class H holds 1.20B in cash and equivalents against 34.22M in total debt, resulting in a net debt position of -954.70M. Total book value stands at 1.76B, with working capital of 1.16B providing operational flexibility.